Ryota Hashimoto

26.1k total citations · 1 hit paper
314 papers, 10.0k citations indexed

About

Ryota Hashimoto is a scholar working on Molecular Biology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Ryota Hashimoto has authored 314 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 88 papers in Psychiatry and Mental health and 81 papers in Cognitive Neuroscience. Recurrent topics in Ryota Hashimoto's work include Schizophrenia research and treatment (55 papers), Genetic Associations and Epidemiology (38 papers) and Autism Spectrum Disorder Research (37 papers). Ryota Hashimoto is often cited by papers focused on Schizophrenia research and treatment (55 papers), Genetic Associations and Epidemiology (38 papers) and Autism Spectrum Disorder Research (37 papers). Ryota Hashimoto collaborates with scholars based in Japan, United States and United Kingdom. Ryota Hashimoto's co-authors include Masatoshi Takeda, Daniel R. Weinberger, Hiroshi Kunugi, Yuka Yasuda, Hidenaga Yamamori, Kazutaka Ohi, De‐Maw Chuang, Dwight Dickinson, Richard E. Straub and Rachel Wallwork and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Ryota Hashimoto

305 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia

2012 627 citations Ryota Hashimoto et al. profile →

Peers

Countries citing papers authored by Ryota Hashimoto

Since Specialization

Citations

This map shows the geographic impact of Ryota Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Hashimoto more than expected).

Fields of papers citing papers by Ryota Hashimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Hashimoto. The network helps show where Ryota Hashimoto may publish in the future.

Co-authorship network of co-authors of Ryota Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Hashimoto. A scholar is included among the top collaborators of Ryota Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Hashimoto. Ryota Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Usefulness of the WAIS‐IV Short Form for Measuring Cognitive Function in Patients With Schizophrenia 2025 ·Neuropsychopharmacology Reports ·Satsuki Ito, Chika Sumiyoshi, Junya Matsumoto, Kenichiro Miura, Yuka Yasuda, Naomi Hasegawa, Harumasa Takano, Tomiki Sumiyoshi, Ryota Hashimoto	0
2	Longitudinal reduction in brain volume in patients with schizophrenia and its association with cognitive function 2024 ·Neuropsychopharmacology Reports ·Ryuichi Yamazaki, Junya Matsumoto, Satsuki Ito, Kiyotaka Nemoto, Masaki Fukunaga, Naoki Hashimoto, Fumitoshi Kodaka, Harumasa Takano, Naomi Hasegawa, Yuka Yasuda, Michiko Fujimoto, Hidenaga Yamamori, Yoshiyuki Watanabe, Kenichiro Miura, Ryota Hashimoto	3
3	Gaze behaviors during free viewing revealed differences in visual salience processing across four major psychiatric disorders: a mega-analysis study of 1012 individuals 2024 ·Molecular Psychiatry ·Kenichiro Miura, Masatoshi Yoshida, Kentaro Morita, Michiko Fujimoto, Yuka Yasuda, Hidenaga Yamamori, Junichi Takahashi, Seiko Miyata, Kosuke Okazaki, Junya Matsumoto, (unknown), Manabu Makinodan, Naoki Hashimoto, Toshiaki Onitsuka, Kiyoto Kasai, Norio Ozaki, Ryota Hashimoto	2
4	Trends in big data analyses by multicenter collaborative translational research in psychiatry 2021 ·Psychiatry and Clinical Neurosciences ·Toshiaki Onitsuka, Yoji Hirano, Kiyotaka Nemoto, Naoki Hashimoto, Itaru Kushima, Daisuke Koshiyama, Michihiko Koeda, Tsutomu Takahashi, Yoshihiro Noda, Junya Matsumoto, Kenichiro Miura, Takanobu Nakazawa, Takatoshi Hikida, Kiyoto Kasai, Norio Ozaki, Ryota Hashimoto	25
5	Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants 2020 ·The International Journal of Neuropsychopharmacology ·Kazutaka Ohi, Daisuke Nishizawa, Takamitsu Shimada, Yuzuru Kataoka, Junko Hasegawa, Toshiki Shioiri, Yasuhiro Kawasaki, Ryota Hashimoto, Kazutaka Ikeda	25
6	Autism-associated protein kinase D2 regulates embryonic cortical neuron development 2019 ·Biochemical and Biophysical Research Communications ·(unknown), Masayuki Baba, Kazuki Nagayasu, Kana Yamamoto, (unknown), (unknown), (unknown), Kaoru Seiriki, Atsushi Kasai, Yukio Ago, Atsuko Hayata‐Takano, Norihito Shintani, Toshihiko Kuriu, Tokuichi Iguchi, Makoto Sato, Kazuhiro Takuma, Ryota Hashimoto, Hitoshi Hashimoto, Takanobu Nakazawa	4
7	Analysis of chemical warfare agents by portable Raman spectrometer with both 785 nm and 1064 nm excitation 2018 ·Forensic Science International ·(unknown), Ryota Hashimoto, (unknown), (unknown), (unknown), (unknown), Yasuo Seto	25
8	Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan 2018 ·Neuropsychopharmacology Reports ·Kenji Miki, Aya Nakae, Kenrin Shi, Yuka Yasuda, Hidenaga Yamamori, Michiko Fujimoto, Manabu Ikeda, Masahiko Shibata, Masao Yukioka, Ryota Hashimoto	9
9	Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects 2016 ·PubMed ·Yoshihiro Kamada, Ryota Hashimoto, Hidenaga Yamamori, Yuka Yasuda, Tetsuo Takehara, Yūkō Fujita, Kenji Hashimoto, Eiji Miyoshi	24
10	Aberrant DNA Methylation of Blood in Schizophrenia by Adjusting for Estimated Cellular Proportions 2014 ·NeuroMolecular Medicine ·Makoto Kinoshita, Shusuke Numata, Atsushi Tajima, Kazutaka Ohi, Ryota Hashimoto, Shinji Shimodera, Issei Imoto, Masatoshi Takeda, Tetsuro Ohmori	29
11	Central CRTH2, a Second Prostaglandin D₂Receptor, Mediates Emotional Impairment in the Lipopolysaccharide and Tumor-Induced Sickness Behavior Model 2014 ·Journal of Neuroscience ·Ryota Haba, Norihito Shintani, Yusuke Onaka, (unknown), (unknown), (unknown), Atsuko Hayata, Hiroyuki Hirai, Kinya Nagata, Masataka Nakamura, Atsushi Kasai, Ryota Hashimoto, Kazuki Nagayasu, Takanobu Nakazawa, Hitoshi Hashimoto, Akemichi Baba	19
12	Analysis of the VAV3 as Candidate Gene for Schizophrenia: Evidences From Voxel-Based Morphometry and Mutation Screening 2012 ·Schizophrenia Bulletin ·Branko Aleksić, Itaru Kushima, Ryota Hashimoto, Kazutaka Ohi, Masashi Ikeda, Akira Yoshimi, Yukako Nakamura, Yoshihito Ito, Tomo Okochi, Yasuhisa Fukuo, Yuka Yasuda, Motoyuki Fukumoto, Hidenaga Yamamori, Hiroshi Ujike, Michio Suzuki, Toshiya Inada, Masatoshi Takeda, Kozo Kaibuchi, Nakao Iwata, Norio Ozaki	16
13	Alg14 organizes the formation of a multiglycosyltransferase complex involved in initiation of lipid-linked oligosaccharide biosynthesis 2011 ·Glycobiology ·Jianming Lü, Toshisada Takahashi, (unknown), Kazuyuki Nakajima, Ryota Hashimoto, Nobuhiko Miura, Hiroyuki Tachikawa, Xiangdong Gao	43
14	Resequencing and Association Analysis of the KALRN and EPHB1 Genes And Their Contribution to Schizophrenia Susceptibility 2010 ·Schizophrenia Bulletin ·Itaru Kushima, Yukako Nakamura, Branko Aleksić, Masashi Ikeda, Yoshihito Ito, Tomoko Shiino, Tomo Okochi, Yasuhisa Fukuo, Hiroshi Ujike, Michio Suzuki, Toshiya Inada, Ryota Hashimoto, Masatoshi Takeda, Kozo Kaibuchi, Nakao Iwata, Norio Ozaki	71
15	A two-stage case–control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects 2010 ·Journal of Human Genetics ·(unknown), Branko Aleksić, Yoshihito Ito, (unknown), Akira Yoshimi, Toshiya Inada, Michio Suzuki, Ryota Hashimoto, Masatoshi Takeda, Nakao Iwata, Norio Ozaki	17
16	Effect of the brain‐derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer’s disease 2008 ·Genes Brain & Behavior ·Ryota Hashimoto, Yoko Hirata, Takashi Asada, Fumio Yamashita, Kiyotaka Nemoto, Taketoshi Mori, Yoshiya Moriguchi, Hiroshi Kunugi, K. Arima, Takashi Ohnishi	41
17	Regulation of Notch Signaling by Dynamic Changes in the Precision of S3 Cleavage of Notch-1 2007 ·Molecular and Cellular Biology ·Shinji Tagami, Masayasu Okochi, Kanta Yanagida, Akiko Ikuta, Akio Fukumori, (unknown), Yoshiko Ishizuka‐Katsura, Taisuke Nakayama, Naohiro Itoh, Jingwei Jiang, Kouhei Nishitomi, Kouzin Kamino, Takashi Morihara, Ryota Hashimoto, Toshihisa Tanaka, Takashi Kudo, Shigeru Chiba, Masatoshi Takeda	94
18	Neuregulin 1 (NRG1) transcripts are differentially expressed in schizophrenia and regulated by 5 ' SNPS associated with the disease 2005 ·Journal of Psychopharmacology ·Amanda J. Law, Barbara K. Lipska, Svenja Weickert, T M Hyde, (unknown), Ryota Hashimoto, Paul J. Harrison, Joel E. Kleinman, (unknown)	2
19	Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation 2002 ·Journal of Neurochemistry ·Ryota Hashimoto, Christopher Hough, Takanobu Nakazawa, Tadashi Yamamoto, De‐Maw Chuang	246
20	Histochemical Study of Acid and Alkaline p-Nitro-phenyl Phosphatases in the Developing Rat Purkinje Cells. 1990 ·ACTA HISTOCHEMICA ET CYTOCHEMICA ·Takao Yoshioka, Hiroyuki Sekimoto, Takashi Hatta, Ryota Hashimoto, Osamu Tanaka	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact